Clinical Trial Update: Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein [Phase 3]

View source ↗

Summary

Phase 3 trial assessing growth and tolerance in healthy infants fed a partially hydrolyzed rice protein formula; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Snippet

Sponsor: Sodilac | Conditions: Growth, Allergy | Phase 3 | Status: COMPLETED